GEN2 Directed Cancer Immunotherapy Trial
Clinical trial NCT04313868 · COMPLETED
Trial details
- NCT number
- NCT04313868
- Sponsor
- GenVivo, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-13
- Primary completion
- 2023-12-12
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.